# Intranasal vs. IV Dexmedetomidine in Endoscopic Sinus Surgery

> **NCT05595083** · NA · UNKNOWN · sponsor: **Kafrelsheikh University** · enrollment: 54 (estimated)

## Conditions studied

- Functional Endoscopic Sinus Surgery
- Dexmedetomidine

## Interventions

- **DRUG:** intranasal dexmedetomidine group
- **DRUG:** intravouns dexmedetomidine group

## Key facts

- **NCT ID:** NCT05595083
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-01
- **Primary completion:** 2023-10-01
- **Final completion:** 2023-10-01
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2023-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05595083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05595083, "Intranasal vs. IV Dexmedetomidine in Endoscopic Sinus Surgery". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT05595083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*